Joinpoint regression analysis of the sex-specific ASRs for PUD globally from 1990 to 2021. by Wende Hao (10315597)

Subjects:

Predicted trends in Age-standardized rates of PUD for both sexes globally over the next 19 years (2022-2040). by Wende Hao (10315597)

Subjects:

Age-specific numbers and rates of PUD globally in 2021 for both sexes. by Wende Hao (10315597)

Subjects:

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

“…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …”

The observed MRM reactions. by Ewa Paszkowska (21246702)

“…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …”

Intra- and inter-day precision and accuracy. by Ewa Paszkowska (21246702)

“…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …”

Joinpoint regression analysis of the trends in age-standardised rates of CRC burden in five East Asian countries, the United States, and globally, 1990–2021. by Yuanyi Cao (22394797)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

Global comparison of incidence, prevalence, deaths and DALYs counts by age group and their crude rates, 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021. by Zhengpeng Li (2322058)

Subjects:

All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 1990. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in global in 2021. by Zhengpeng Li (2322058)

Subjects:

APC of ASIR, ASPR, ASMR and ASDR for global RA from1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

APC of ASIR, ASPR, ASMR and ASDR for China RA from 1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in global in 1990. by Zhengpeng Li (2322058)

Subjects:

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. by Peiqi Yin (6533747)